EKSL PHARMA LLP
LLPIN: ACY-1497 Active
Full company report
Balance sheet and P&L, charges, auditors, resolutions, funding, MSME dues and complaints, checked by our team.
₹999 + GST · delivered in 3 working days
Get full reportAlready bought it? View it in your account
Company information
EKSL PHARMA LLP (ACY-1497) is a limited liability partnership incorporated on 14 May 2026. It is a company and is registered with the ROC Haryana. It is engaged in trading. Its registered office is at SHOP F-43,Apex our bazar,Sector 37C,Gurgaon,Gurgaon,Haryana,India-122001.
The current status of EKSL PHARMA LLP is Active.
Basic information
- LLPIN
- ACY-1497
- Name
- EKSL PHARMA LLP
- Company status
- Active
- ROC
- ROC Haryana
- Date of incorporation
- 14 May 2026
- Age of company
- 5 months, 25 days
- Activity
- Trading
Annual compliance status
- Date of last annual general meeting
- Not available yet
- Date of latest balance sheet
- Not available yet
Key numbers
- Authorised share capital
- Not available
- Paid-up share capital
- Not available
- Total assets
- Included in the full report
- Revenue
- Included in the full report
- Profit after tax
- Included in the full report
- Employee benefit expenses
- Included in the full report
Designated partners of EKSL PHARMA LLP
As per records filed with the Ministry of Corporate Affairs.
Designated partners are not on our records yet
The full report lists current and past designated partners with DIN and appointment dates. If you know them, tell us and we'll update this page after checking MCA records.
Contact details of EKSL PHARMA LLP
- Not available
- Registered office
- SHOP F-43,Apex our bazar,Sector 37C,Gurgaon,Gurgaon,Haryana,India-122001
- City, state and PIN
- Haryana – 122001
See the full picture of EKSL PHARMA LLP
The sections below are filled in your report from official MCA filings: financial statements, charges, auditors, resolutions, funding, MSME dues and complaints.
Balance sheet of EKSL PHARMA LLP
In full report
Assets, liabilities and equity as filed in the annual financial statements (AOC-4), for up to the last 5 financial years.
| Particulars | FY 2025-26 |
|---|---|
| Equity And Liabilities | |
| Share capital | |
| Reserves and surplus | |
| Long-term borrowings | |
| Other long-term liabilities | |
| Long-term provisions | |
| Short-term borrowings | |
| Trade payables | |
| Other current liabilities | |
| Short-term provisions | |
| Total equity and liabilities | |
| Assets | |
| Property, plant and equipment | |
| Intangible assets | |
| Capital work in progress | |
| Non-current investments | |
| Long-term loans and advances | |
| Current investments | |
| Inventories | |
| Trade receivables | |
| Cash and bank balances | |
| Short-term loans and advances | |
| Other current assets | |
| Total assets | |
Profit and loss statement of EKSL PHARMA LLP
In full report
Revenue, expenses and profit as filed in the annual financial statements, for up to the last 5 financial years.
| Particulars | FY 2025-26 |
|---|---|
| Revenue from operations | |
| Other income | |
| Total income | |
| Cost of materials consumed | |
| Purchases of stock in trade | |
| Employee benefit expenses | |
| Finance costs | |
| Depreciation and amortisation | |
| Other expenses | |
| Total expenses | |
| Profit before tax | |
| Current tax | |
| Deferred tax | |
| Profit after tax | |
| Earnings per share (basic) | |
| Earnings per share (diluted) |
Charges (secured loans) of EKSL PHARMA LLP
In full report
Loans secured against the company's assets and registered with the ROC: lender, amount and whether the charge is open or satisfied.
| Charge ID | Charge holder | Amount (₹) | Created on | Modified on | Satisfied on | Assets under charge | Status |
|---|---|---|---|---|---|---|---|
Auditors of EKSL PHARMA LLP
In full report
Statutory auditors appointed by the company over the years, as reported in its annual filings.
| Financial year | Auditor / firm | Firm registration no. | Signing partner | Membership no. | Appointed on |
|---|---|---|---|---|---|
Board meetings and resolutions of EKSL PHARMA LLP
In full report
Resolutions passed by the board or shareholders and filed with the Registrar of Companies (MGT-14).
| Date of filing | Date of resolution | Section | Subject of resolution | Resolution type | Agreed by |
|---|---|---|---|---|---|
Fund raising and allotments of EKSL PHARMA LLP
In full report
Shares or debentures allotted by the company (PAS-3), including any funding raised from investors.
| Date of allotment | Security type | Number of securities | Nominal value (₹) | Premium (₹) | Total amount (₹) | Allotted to |
|---|---|---|---|---|---|---|
Subsidiaries, associates and joint ventures of EKSL PHARMA LLP
In full report
Holding, subsidiary, associate and joint venture companies as per the latest annual return.
| CIN / identifier | Name | Relationship | Shares held (%) |
|---|---|---|---|
Outstanding payments to micro and small enterprises of EKSL PHARMA LLP
In full report
Half-yearly MSME-1 returns of payments the company has delayed beyond 45 days to micro and small suppliers.
| Return period | Filed on | Amount due (₹) | Days outstanding | Reason for delay |
|---|---|---|---|---|
Complaints of EKSL PHARMA LLP
In full report
Investor complaints and serious complaints recorded against the company or its directors with the Registrar.
| Date | Complaint type | Against | Particulars | Status |
|---|---|---|---|---|
Similar companies
Other companies in 122001
- TERRANANO BIO AGRITECH PRIVATE LIMITED2026
- MS RARA TECH ADVISORY LLP2026
- AEVTRIX CONSULTING (OPC) PRIVATE LIMITED2026
- NEXORA JK PRIVATE LIMITED2026
- VESTA HOME RETAIL LLP2026
- CULTURE CAULDRON LLP2026
- WEAFIX STUDIOS LLP2026
- ANAND INFRA & ENGINEERING LLP2026
- FORUMAXIS NETWORKS PRIVATE LIMITED2026
- ZEVOR WORKFORCE SOLUTIONS PRIVATE LIMITED2026
Update information
Last updated on: 08 Nov 2026, 12:18 PM
Is this information out of date, or does something not match? Tell us and we will check it against the latest MCA records.
Is this your llp?
Annual ROC filings, GST, TDS and bookkeeping, handled by one team with live reports in Genie.